Literature DB >> 12829130

Tumor microcirculation and diffusion predict therapy outcome for primary rectal carcinoma.

Alexander F DeVries1, Christian Kremser, Patrick A Hein, Jürgen Griebel, Alfons Krezcy, Dietmar Ofner, Karl Peter Pfeiffer, Peter Lukas, Werner Judmaier.   

Abstract

PURPOSE: The aim of our study was to correlate perfusion indices and apparent diffusion coefficients with therapy outcome after chemoradiation. METHODS AND MATERIALS: In 34 patients with primary rectal carcinoma (cT3) undergoing preoperative chemoradiation, pretherapeutic perfusion indices and apparent diffusion coefficients were obtained by dynamic or diffusion-weighted magnetic resonance imaging. Therapy response was defined if the pathologic observation revealed no invasion into the perirectal fat after chemoradiation.
RESULTS: In 18 patients, a response and in 16, no response was observed. Statistically significant differences were found for the mean perfusion index (p < 0.001; 7.5 +/- 1.5 mL/min/100 g vs. 10.7 +/- 2.7 mL/min/100 g) and for the intratumoral cumulative fraction of pixels with perfusion-indices > 12 mL/min/100 g (p < 0.001, 3.7 +/- 4.0% vs. 24.7 +/- 17.9%). A three-way ANOVA resulted in significant effects for therapy responder/nonresponder (p < 0.001) and for apparent diffusion coefficient and the individual patients.
CONCLUSION: Perfusion indices and apparent diffusion coefficients inside the tumor region seem to be of predictive value for therapy outcome of preoperative therapy in patients with primary rectal carcinoma. Higher parameter levels in the nonresponding group could be explained by increased shunt flow or increased angiogenic activity in aggressive tumor cell clusters resulting in reduced nutrients supply and higher fraction of intratumoral necrosis respectively.

Entities:  

Mesh:

Year:  2003        PMID: 12829130     DOI: 10.1016/s0360-3016(03)00208-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  70 in total

Review 1.  Imaging-based tumor treatment response evaluation: review of conventional, new, and emerging concepts.

Authors:  Hee Kang; Ho Yun Lee; Kyung Soo Lee; Jae-Hun Kim
Journal:  Korean J Radiol       Date:  2012-06-18       Impact factor: 3.500

2.  Diffusion-weighted magnetic resonance imaging for prediction of tumor response to neoadjuvant chemoradiotherapy using irinotecan plus S-1 for rectal cancer.

Authors:  Hiroshi Doi; Naohito Beppu; Takashi Kato; Masashi Noda; Hidenori Yanagi; Naohiro Tomita; Norihiko Kamikonya; Shozo Hirota
Journal:  Mol Clin Oncol       Date:  2015-07-21

3.  Diffusion-weighted magnetic resonance imaging for predicting the response of rectal cancer to neoadjuvant concurrent chemoradiation.

Authors:  Gang Cai; Ye Xu; Ji Zhu; Wei-Lie Gu; Shuai Zhang; Xue-Jun Ma; San-Jun Cai; Zhen Zhang
Journal:  World J Gastroenterol       Date:  2013-09-07       Impact factor: 5.742

Review 4.  Extracranial applications of diffusion-weighted magnetic resonance imaging.

Authors:  Harriet C Thoeny; Frederik De Keyzer
Journal:  Eur Radiol       Date:  2007-01-06       Impact factor: 5.315

5.  Multiparametric MRI biomarkers for measuring vascular disrupting effect on cancer.

Authors:  Huaijun Wang; Guy Marchal; Yicheng Ni
Journal:  World J Radiol       Date:  2011-01-28

6.  Dynamic contrast-enhanced and diffusion MRI show rapid and dramatic changes in tumor microenvironment in response to inhibition of HIF-1alpha using PX-478.

Authors:  Bénédicte F Jordan; Matthew Runquist; Natarajan Raghunand; Amanda Baker; Ryan Williams; Lynn Kirkpatrick; Garth Powis; Robert J Gillies
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

7.  Apparent diffusion coefficient for evaluating tumour response to neoadjuvant chemoradiation therapy for locally advanced rectal cancer.

Authors:  Seung Ho Kim; Jae Young Lee; Jeong Min Lee; Joon Koo Han; Byung Ihn Choi
Journal:  Eur Radiol       Date:  2010-10-27       Impact factor: 5.315

8.  Multimodal imaging for early functional response assessment of (90)Y-/ (177)Lu-DOTATOC peptide receptor targeted radiotherapy with DW-MRI and (68)Ga-DOTATOC-PET/CT.

Authors:  Sarah Wulfert; Clemens Kratochwil; Peter L Choyke; Ali Afshar-Oromieh; Walter Mier; Hans-Ulrich Kauczor; Jens-Peter Schenk; Uwe Haberkorn; Frederik L Giesel
Journal:  Mol Imaging Biol       Date:  2014-08       Impact factor: 3.488

Review 9.  The role of functional imaging in the era of targeted therapy of renal cell carcinoma.

Authors:  Margarita Braunagel; Anno Graser; Maximilian Reiser; Mike Notohamiprodjo
Journal:  World J Urol       Date:  2013-04-16       Impact factor: 4.226

10.  Magnetic resonance-guided focused ultrasound for the treatment of painful bone metastases: role of apparent diffusion coefficient (ADC) and dynamic contrast enhanced (DCE) MRI in the assessment of clinical outcome.

Authors:  Michele Anzidei; Alessandro Napoli; Beatrice Sacconi; Fabrizio Boni; Vincenzo Noce; Michele Di Martino; Luca Saba; Carlo Catalano
Journal:  Radiol Med       Date:  2016-08-27       Impact factor: 3.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.